Bromobenzenes

Organic compounds considered aryl halides that consist of a phenyl group with a bromine atom substitution in the following structure: C₆H₅Br.

Search Within Results

571 – 585 of 1,705 results

571

eMolecules 1956327-16-4 | 5-Bromo-2-(trifluoromethoxy)phenylacetic acid | Apollo Scientific | MFCD29920603 | 299.043 | C9H6BrF3O3 | 95.000 | OC(=O)Cc1cc(Br)ccc1OC(F)(F)F | 1g | 591806797

5-Bromo-2-(trifluoromethoxy)phenylacetic acid | Apollo Scientific | 1956327-16-4 | MFCD29920603 | 299.043 | C9H6BrF3O3 | 95.000 | OC(=O)Cc1cc(Br)ccc1OC(F)(F)F | 1g | 591806797

Pricing & Availability

572

eMolecules 900573-88-8 | JI-101 | MFCD18633251 | 0.1g

AstaTech | JI-101 | 0.1g | 464144574 | 40122 | 95.000 | 900573-88-8 | MFCD18633251 | 502.800 | C22H21BrClN5O2

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>

Pricing & Availability

573

eMolecules 5467-74-3 | 4-Bromobenzeneboronic acid | Ambeed | MFCD00002104 | 200.830 | C6H6BBrO2 | 97.000 | OB(O)c1ccc(Br)cc1 | 100g | 552613473

4-Bromobenzeneboronic acid | Ambeed | 5467-74-3 | MFCD00002104 | 200.830 | C6H6BBrO2 | 97.000 | OB(O)c1ccc(Br)cc1 | 100g | 552613473

Pricing & Availability

574

eMolecules 5467-74-3 | 4-Bromobenzeneboronic acid | Ambeed | MFCD00002104 | 200.830 | C6H6BBrO2 | 97.000 | OB(O)c1ccc(Br)cc1 | 1g | 552613468

4-Bromobenzeneboronic acid | Ambeed | 5467-74-3 | MFCD00002104 | 200.830 | C6H6BBrO2 | 97.000 | OB(O)c1ccc(Br)cc1 | 1g | 552613468

Pricing & Availability

575

eMolecules 7099-87-8 | 2-(4-BROMOPHENYL)-2-OXOACETIC ACID | AstaTech | MFCD07698695 | 229.029 | C8H5BrO3 | 95.000 | OC(=O)C(=O)c1ccc(Br)cc1 | 1g | 402180959

2-(4-BROMOPHENYL)-2-OXOACETIC ACID | AstaTech | 7099-87-8 | MFCD07698695 | 229.029 | C8H5BrO3 | 95.000 | OC(=O)C(=O)c1ccc(Br)cc1 | 1g | 402180959

Pricing & Availability

576

eMolecules 5467-74-3 | 4-Bromobenzeneboronic acid | Ambeed | MFCD00002104 | 200.830 | C6H6BBrO2 | 97.000 | OB(O)c1ccc(Br)cc1 | 10g | 552613471

4-Bromobenzeneboronic acid | Ambeed | 5467-74-3 | MFCD00002104 | 200.830 | C6H6BBrO2 | 97.000 | OB(O)c1ccc(Br)cc1 | 10g | 552613471

Pricing & Availability

577

eMolecules 5467-74-3 | 4-Bromobenzeneboronic acid | Ambeed | MFCD00002104 | 200.830 | C6H6BBrO2 | 97.000 | OB(O)c1ccc(Br)cc1 | 5g | 552613470

4-Bromobenzeneboronic acid | Ambeed | 5467-74-3 | MFCD00002104 | 200.830 | C6H6BBrO2 | 97.000 | OB(O)c1ccc(Br)cc1 | 5g | 552613470

Pricing & Availability

578

eMolecules 5467-74-3 | 4-Bromobenzeneboronic acid | Ambeed | MFCD00002104 | 200.830 | C6H6BBrO2 | 97.000 | OB(O)c1ccc(Br)cc1 | 500g | 490522385

4-Bromobenzeneboronic acid | Ambeed | 5467-74-3 | MFCD00002104 | 200.830 | C6H6BBrO2 | 97.000 | OB(O)c1ccc(Br)cc1 | 500g | 490522385

Pricing & Availability

579

eMolecules 40753-13-7 | 4-(4-Bromophenyl)-1,2,3-thiadiazole | Oakwood Chemical | MFCD00084907 | 241.110 | C8H5BrN2S | 97.000 | Brc1ccc(cc1)-c1csnn1 | 1g | 537706230

4-(4-Bromophenyl)-1,2,3-thiadiazole | Oakwood Chemical | 40753-13-7 | MFCD00084907 | 241.110 | C8H5BrN2S | 97.000 | Brc1ccc(cc1)-c1csnn1 | 1g | 537706230

Pricing & Availability

580

eMolecules 1008769-87-6 | 4-Bromo-3-(trifluoromethoxy)benzoic acid | Apollo Scientific | MFCD22378818 | 285.016 | C8H4BrF3O3 | 97.000 | OC(=O)c1ccc(Br)c(OC(F)(F)F)c1 | 1g | 562428144

4-Bromo-3-(trifluoromethoxy)benzoic acid | Apollo Scientific | 1008769-87-6 | MFCD22378818 | 285.016 | C8H4BrF3O3 | 97.000 | OC(=O)c1ccc(Br)c(OC(F)(F)F)c1 | 1g | 562428144

Pricing & Availability

581

eMolecules 59734-92-8 | 1-Bromo-2-cyclohexylbenzene | Combi-Blocks, Inc. | MFCD02093987 | 239.156 | C12H15Br | 97.000 | Brc1ccccc1C1CCCCC1 | 1g | 603146100

1-Bromo-2-cyclohexylbenzene | Combi-Blocks, Inc. | 59734-92-8 | MFCD02093987 | 239.156 | C12H15Br | 97.000 | Brc1ccccc1C1CCCCC1 | 1g | 603146100

Pricing & Availability

582

Medchemexpress LLC Proteasome inhibitor IX (PS-IX; AM114) | 856849-35-9 | 99.4% | 377.01 | C20H21B2NO5 | 10 MG

Proteasome inhibitor IX (PS-IX; AM114) is a chalcone-derived small molecule research reagent that inhibits the chymotrypsin-like activity of the 20S proteasome with an IC50 of approximately 1 μM. It is supplied as a light yellow solid intended for in vitro studies of proteasome function and anticancer mechanisms.

Inhibits chymotrypsin-like activity of 20S proteasome (IC50 ≈ 1 μM).
Chalcone-derived small molecule suitable for biochemical and cell-based assays.
High purity (99.4%) for reproducible results.
Molecular weight 377.01 and formula C20H21B2NO5.
Supplied as a light yellow solid for convenient handling and storage.

Pricing & Availability

583

Medchemexpress LLC IL-17A antagonist 1 | 2205034-18-8 | MFCD32693918 | 99.7% | 604.71 g/mol | C33H41FN6O4 | 100 MG

IL-17A antagonist 1 is a research-grade small-molecule antagonist of interleukin-17A designed for biochemical binding assays and cellular pharmacology studies. It exhibits a reported Kd of 0.66 μM and an IC50 of 1.14 nM, and is supplied as a characterized solid with validated solubility and stability data for in vitro and in vivo use.

High reported purity of 99.74%.
Defined binding affinity and inhibitory potency for IL-17A.
Soluble in DMSO at 41.67 mg/mL and usable in validated in vivo formulations.
Stable under recommended storage conditions for long-term use.
Provided in multiple solid pack sizes and a solution format for convenience.

Pricing & Availability

584

Medchemexpress LLC 3-[4-[(3S)-4-(4-Br-benzoyl)-3-(4-Cl-phenyl)piperazine-1-carbonyl]-5-methylpyrazol-1-yl]benzonitrile | 2095486-67-0 | 100.0% | 588.88 g/mol | C29H23BrClN5O2 | 100 MG

eIF4A3-IN-1 is a small-molecule inhibitor of the eukaryotic initiation factor eIF4A3 used as a research tool in cellular and animal studies. It selectively binds a non-ATP site on eIF4A3 and has reported antitumor and analgesic activities; supplied as a high-purity solid suitable for in vitro and in vivo applications.

Selective eIF4A3 inhibition
High purity (99.96%)
Available in multiple sizes, including 100 mg
High solubility in DMSO (200 mg/mL) for in vitro use
Formulation guidance for in vivo dosing (10% DMSO, 90% corn oil)
Stable with long-term powder storage at -20 °C

Pricing & Availability

585

Medchemexpress LLC Androgen receptor antagonist 1 | 1338812-36-4 | 99.7% | C21H25ClN4O3 | 10MG

Androgen receptor antagonist 1 is a small-molecule research compound (CAS 1338812-36-4) reported to act as a full androgen receptor antagonist used in preclinical studies and cell-based assays to probe AR signaling. The compound has molecular formula C21H25ClN4O3, molecular weight ~416.9 g·mol⁻¹, and is listed with high reported purity by commercial suppliers.

High reported purity (~99.7%) for reproducible results.
Full androgen receptor antagonist activity for AR pathway studies.
Suitable for cell-based and biochemical assays.
Soluble formulations available for convenient assay preparation.
Well-defined molecular properties (C21H25ClN4O3; MW ~416.9) for characterization.

Pricing & Availability

Bromobenzenes

Filtered Search Results

Narrow Results

Medchemexpress LLC Proteasome inhibitor IX (PS-IX; AM114) | 856849-35-9 | 99.4% | 377.01 | C20H21B2NO5 | 10 MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC IL-17A antagonist 1 | 2205034-18-8 | MFCD32693918 | 99.7% | 604.71 g/mol | C33H41FN6O4 | 100 MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC Androgen receptor antagonist 1 | 1338812-36-4 | 99.7% | C21H25ClN4O3 | 10MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC Proteasome inhibitor IX (PS-IX; AM114) | 856849-35-9 | 99.4% | 377.01 | C20H21B2NO5 | 10 MG

Medchemexpress LLC IL-17A antagonist 1 | 2205034-18-8 | MFCD32693918 | 99.7% | 604.71 g/mol | C33H41FN6O4 | 100 MG

Medchemexpress LLC Androgen receptor antagonist 1 | 1338812-36-4 | 99.7% | C21H25ClN4O3 | 10MG